ATE178096T1 - Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzen - Google Patents
Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzenInfo
- Publication number
- ATE178096T1 ATE178096T1 AT92900907T AT92900907T ATE178096T1 AT E178096 T1 ATE178096 T1 AT E178096T1 AT 92900907 T AT92900907 T AT 92900907T AT 92900907 T AT92900907 T AT 92900907T AT E178096 T1 ATE178096 T1 AT E178096T1
- Authority
- AT
- Austria
- Prior art keywords
- virus
- monoclonal antibodies
- hepatitis
- antibodies against
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
- C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61017590A | 1990-11-07 | 1990-11-07 | |
| US64847791A | 1991-01-31 | 1991-01-31 | |
| US64847391A | 1991-01-31 | 1991-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE178096T1 true ATE178096T1 (de) | 1999-04-15 |
Family
ID=27417025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92900907T ATE178096T1 (de) | 1990-11-07 | 1991-11-07 | Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzen |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0556320B1 (de) |
| JP (3) | JP3242402B2 (de) |
| KR (1) | KR930702507A (de) |
| AT (1) | ATE178096T1 (de) |
| AU (1) | AU662503B2 (de) |
| CA (1) | CA2095735C (de) |
| DE (1) | DE69131046T2 (de) |
| DK (1) | DK0556320T3 (de) |
| ES (1) | ES2132115T3 (de) |
| GR (1) | GR3030212T3 (de) |
| TW (1) | TW206235B (de) |
| WO (1) | WO1992008738A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69225960T2 (de) * | 1991-01-31 | 1999-01-21 | Abbott Laboratories, Abbott Park, Ill. | Monoklonale antikörper gegen mögliche hcv-hüllregionen und methoden diese zu benutzen |
| JP3217600B2 (ja) * | 1994-07-12 | 2001-10-09 | 株式会社先端生命科学研究所 | 非a非b型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ |
| JP2001512560A (ja) * | 1996-10-08 | 2001-08-21 | ユー―ビスイス ベスローテン フェンノートシャップ | 標的に対し特異的な親和性を有するペプチドおよびタンパク質の選択のための方法および手段 |
| US6329157B1 (en) | 1998-05-28 | 2001-12-11 | Abbott Laboratories | Antigen cocktails and uses thereof |
| CA2316130A1 (en) * | 1999-08-19 | 2001-02-19 | Masanori Fukui | Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein |
| US20030232386A1 (en) * | 2002-06-17 | 2003-12-18 | Shah Dinesh O. | Assay conjugate and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486530A (en) * | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| BR8807310A (pt) * | 1987-11-18 | 1990-03-13 | Chiron Corp | Polinucleotidio,polinucleotidio recombinante,vetor recombinante,celula hospedeira,sistema de expressao recombinante,celula transformada,polipeptidio,hcv,preparacao de polipeptidio,polipeptidio de hcv,polipeptidio purificado,polipeptidio recombinante,polipeptidio de fusao,anticorpo monoclonal,preparacao purificada de anticorpos policlonais,particula,sonda de polinucleotidio,kit anticorpo para epetopo de hcv,metodo para producao de polipeptidio,metodo para deteccao de acidos nucleicos de hcv,imunoensaio para detectar antigeno de hcv,imunoensaio para detectar anticorpos dirigidos contra antigeno de hcv,vacina para tratamento de infeccao de hcv,celula,celula infectada com hcv,metodo para producao de anticorpos para hcv e metodo para isolar cdna derivado do genoma de um agente infeccioso nao identificado |
| AU624105B2 (en) * | 1987-11-18 | 1992-06-04 | Novartis Vaccines And Diagnostics, Inc. | Nanbv diagnostics and vaccines |
| US5124255A (en) | 1988-03-11 | 1992-06-23 | Abbott Laboratories | CKS method of protein synthesis |
| AU640620B2 (en) * | 1988-12-23 | 1993-09-02 | Neil Kenneth Robinson | Disabled persons wheelchair transfer sliding board |
| HU225068B1 (en) * | 1989-03-17 | 2006-05-29 | Chiron Corp | Process for producing diagnostics and vaccine of nanbh |
| KR940000755B1 (ko) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드 |
| CA2093919A1 (en) * | 1990-10-12 | 1992-04-13 | Mahlon F. Miller | Hepatitis c virus antibody |
| US5574132A (en) * | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
| ZA927837B (en) * | 1991-10-15 | 1994-03-11 | Akzo Nv | Monoclonal antibodiesto hepatitis C virus |
-
1991
- 1991-11-07 KR KR1019930701354A patent/KR930702507A/ko not_active Withdrawn
- 1991-11-07 AU AU90777/91A patent/AU662503B2/en not_active Expired - Fee Related
- 1991-11-07 AT AT92900907T patent/ATE178096T1/de not_active IP Right Cessation
- 1991-11-07 DE DE69131046T patent/DE69131046T2/de not_active Expired - Lifetime
- 1991-11-07 DK DK92900907T patent/DK0556320T3/da active
- 1991-11-07 WO PCT/US1991/008273 patent/WO1992008738A1/en not_active Ceased
- 1991-11-07 CA CA002095735A patent/CA2095735C/en not_active Expired - Lifetime
- 1991-11-07 JP JP50225692A patent/JP3242402B2/ja not_active Expired - Lifetime
- 1991-11-07 ES ES92900907T patent/ES2132115T3/es not_active Expired - Lifetime
- 1991-11-07 EP EP92900907A patent/EP0556320B1/de not_active Expired - Lifetime
- 1991-11-22 TW TW080109191A patent/TW206235B/zh active
-
1999
- 1999-05-13 GR GR990401297T patent/GR3030212T3/el unknown
-
2001
- 2001-04-19 JP JP2001120859A patent/JP3292727B2/ja not_active Expired - Lifetime
- 2001-04-19 JP JP2001120871A patent/JP3292728B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GR3030212T3 (en) | 1999-08-31 |
| JP3292727B2 (ja) | 2002-06-17 |
| CA2095735A1 (en) | 1992-05-08 |
| WO1992008738A1 (en) | 1992-05-29 |
| EP0556320A1 (de) | 1993-08-25 |
| ES2132115T3 (es) | 1999-08-16 |
| DE69131046D1 (de) | 1999-04-29 |
| DK0556320T3 (da) | 1999-10-18 |
| JP3242402B2 (ja) | 2001-12-25 |
| JP2002012600A (ja) | 2002-01-15 |
| KR930702507A (ko) | 1993-09-09 |
| JP2002000267A (ja) | 2002-01-08 |
| TW206235B (de) | 1993-05-21 |
| EP0556320A4 (en) | 1994-11-23 |
| JP3292728B2 (ja) | 2002-06-17 |
| EP0556320B1 (de) | 1999-03-24 |
| AU9077791A (en) | 1992-06-11 |
| AU662503B2 (en) | 1995-09-07 |
| DE69131046T2 (de) | 1999-10-21 |
| CA2095735C (en) | 2004-02-03 |
| JPH06502076A (ja) | 1994-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69230146D1 (de) | Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung | |
| CA2469833A1 (en) | Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them | |
| DE60231651D1 (de) | Proteinreinigungsverfahren | |
| DK0627002T3 (da) | Kloning og ekspression af humaniserede monoklonale antistoffer mod human interleukin-4 | |
| FI942369A0 (fi) | Hepatitis-C-virustesti | |
| PT1308507E (pt) | Anticorpo monoclonal anti-núcleo de hcv | |
| DE69128273D1 (de) | Für toxin b von clostridium difficile spezifische monoklonale antikörper | |
| DE3750339D1 (de) | HTLV-III umhüllende Peptiden. | |
| DE60129278D1 (de) | Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen | |
| ATE103002T1 (de) | Menschlicher monoklonaler antikoerper gegen lymphadenopathie assozierten virus. | |
| DE3584872D1 (de) | Verfahren zur herstellung von monoklonalen antikoerpern gegen hbsag. | |
| DE69131046D1 (de) | Monoklonale antikörper gegen den hepatitis c-virus und verfahren diese zu benutzen | |
| DK26587A (da) | Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette | |
| ATE206621T1 (de) | Il-8 antagonisten zur behandlung von asthma | |
| ATE167522T1 (de) | Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen | |
| DE69224134D1 (de) | Monoklonale Antikörper gegen Hepatitis-C-Virus | |
| DE59508137D1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
| DE3786090D1 (de) | Monoklonale antikoerper und verfahren zum nachweis von pathogenen pilzen. | |
| DE50212790D1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
| ATE294237T1 (de) | S?ugetier thymokingene | |
| ATE174060T1 (de) | Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden | |
| ATE222927T1 (de) | Monoklonaler antikörper gegen den tumorzytotoxischen faktor ii (tcf-ii) | |
| DE3787220D1 (de) | Monoklonaler Antikörper gegen menschliches Plasminogen, Verfahren zu seiner Herstellung, diesen Antikörper enthaltendes Testreagenz sowie Testsatz und diesen Antikörper produzierendes Hybridoma. | |
| BR0204612A (pt) | Anticorpos monoclonais antinúcleo de hcv | |
| DE69331796D1 (de) | Kernantigenprotein des Hepatitis C-Virus, sowie diagnostisches Verfahren und Satz von Reagenzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EELA | Cancelled due to lapse of time |